Boston Scientific Corp.
NYSE:BSX
Other Pre-Announcement
Boston Scientific Posts Q4 Net Income Of $0.09 Per Share
Published: 02/01/2023 12:00 GMT
Boston Scientific Corp. (BSX) - Boston Scientific Announces Results for Fourth Quarter and Full Year 2022.
Qtrly Reported GAAP Net Income Available to Common Stockholders of $0.09 per Share.
Qtrly Adjusted EPS of $0.45 per Share.
Estimates Net Sales Growth for Full Year 2023 About 6 to 8 Percent on an Organic Basis.
Sees Full Year 2023 EPS on a GAAP Basis in a Range of $1.11 to $1.21.
Sees Full Year 2023 Adjusted Eps, Excluding Certain Charges (credits) of $1.86 to $1.93.
Boston Scientific -sees Net Sales Growth for Q1 2023, Versus Prior Year Period, to Be in a Range of About 3 to 5 Percent on a Reported Basis.
Sees Net Sales Growth for Q1 of 2023 Approximately 6 to 8 Percent on an Organic Basis.
Boston Scientific -sees Q1 EPS on GAAP Basis in a Range of $0.23 to $0.26 and Adjusted Eps, Excluding Certain Charges (credits) of $0.42 to $0.44.
FY2023 Earnings per Share View $1.93, Revenue View $13.46 Billion -- Refinitiv Ibes Data (analyst estimates).
Q1 Earnings per Share View $0.44, Revenue View $3.17 Billion -- Refinitiv Ibes Data (analyst estimates).
Qtrly Reported GAAP Net Income Available to Common Stockholders of $0.09 per Share.
Qtrly Adjusted EPS of $0.45 per Share.
Estimates Net Sales Growth for Full Year 2023 About 6 to 8 Percent on an Organic Basis.
Sees Full Year 2023 EPS on a GAAP Basis in a Range of $1.11 to $1.21.
Sees Full Year 2023 Adjusted Eps, Excluding Certain Charges (credits) of $1.86 to $1.93.
Boston Scientific -sees Net Sales Growth for Q1 2023, Versus Prior Year Period, to Be in a Range of About 3 to 5 Percent on a Reported Basis.
Sees Net Sales Growth for Q1 of 2023 Approximately 6 to 8 Percent on an Organic Basis.
Boston Scientific -sees Q1 EPS on GAAP Basis in a Range of $0.23 to $0.26 and Adjusted Eps, Excluding Certain Charges (credits) of $0.42 to $0.44.
FY2023 Earnings per Share View $1.93, Revenue View $13.46 Billion -- Refinitiv Ibes Data (analyst estimates).
Q1 Earnings per Share View $0.44, Revenue View $3.17 Billion -- Refinitiv Ibes Data (analyst estimates).